Nausea and Vomiting Nausea from GLP 1 drugs is the most frequently reported symptom
Our telehealth platform provides access to licensed healthcare providers in Slidell, Louisiana, who can prescribe this FDA-approved medication to help you achieve your health goals
By following these guidelines, you can effectively monitor your response to semaglutide at home
Track your skin's trajectory over two to three weeks
Thats exactly who should be getting this therapy. Targeting Alstrm Syndrome In Effectiveness of the Dual GIP/GLP1-Agonist Tirzepatide in 2 Cases of Alstrm Syndrome, a Rare Obesity Syndrome , published in JCEM in April, Thomas Scherer, MD, of the Medical University of Vienna, in Vienna, Austria, and team showed tirzepatides efficacy even in the particularly difficult-to-treat Alstrm syndrome (AS), a rare, genetic, multisystemic disorder, characterized by, among other conditions, diabetes with profound insulin resistance due to marked hyperphagia
Retatrutide is currently in phase 3 clinical trials and has not yet been approved by the FDA